Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2018

Open Access 01-12-2018 | Review

Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer

Authors: Yi Hou, Xudong Wang, Jing Chen

Published in: World Journal of Surgical Oncology | Issue 1/2018

Login to get access

Abstract

Background

To demonstrate the prognostic significance and value of lymph node ratio (LNR) and evaluate the possibility of becoming a new indicator to enhance the current Union for International Cancer Control (UICC)/American Joint Committee on Cancer (AJCC) tumor, lymph node, metastasis (TNM) staging system.

Methods

Our retrospective study included 221 patients who got gastric cancer and underwent curative gastrectomy between 2005 and 2012 at the Fourth Hospital Affiliated of China Medical University. The log-rank test was used to compare the clinicopathological variables. The Kaplan-Meier method and Cox proportional hazard regression model was used to perform the univariate analysis and multivariate statistical survival analysis.

Results

The patients with a better differentiated pathological type; an earlier stage of T staging, N staging, and TNM staging; and a lesser LNR would have a longer survival time according to the univariate analysis. As for the multivariate analysis, the Grade, T stage, N stage, and LNR had the statistical significance. Both in group 1 (the number of lymph nodes examined ≥ 15, namely LN ≥ 15) and group 2 (LN < 15), the LNR had statistical significance and the median survival time would decrease with the increase of the LNR. It was still statistically significant between group LNR1 and group LNR2 which were regrouped by the new cut-off value.

Conclusion

The LNR could estimate the prognosis of patients with curative gastrectomy regardless of the number of lymph nodes examined. Thus LNR could become a new indicator to enhance the current TNM stage system.
Literature
1.
go back to reference MD WCPD, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. Ca A Cancer J Clinicians. 2016;66(2):115–32.CrossRef MD WCPD, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. Ca A Cancer J Clinicians. 2016;66(2):115–32.CrossRef
2.
go back to reference Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world [J]. J Clin Oncol. 2006;24(14):2137–50.CrossRef Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world [J]. J Clin Oncol. 2006;24(14):2137–50.CrossRef
3.
go back to reference Coburn NG, Swallow CJ, Kiss A, et al. Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. [J]. Cancer. 2006;107(9):2143–51.CrossRef Coburn NG, Swallow CJ, Kiss A, et al. Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. [J]. Cancer. 2006;107(9):2143–51.CrossRef
4.
go back to reference Sobin LHGM, Wittekind CH. International Union Against Cancer (UICC) TNM classification of malignant tumors. 7th ed. New York: Wiley-Lwass; 2010. Sobin LHGM, Wittekind CH. International Union Against Cancer (UICC) TNM classification of malignant tumors. 7th ed. New York: Wiley-Lwass; 2010.
5.
go back to reference Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC Cancer staging manual. 7th ed. New York: Springer; 2010. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC Cancer staging manual. 7th ed. New York: Springer; 2010.
6.
go back to reference Pedrazzani C, Sivins A, et al. Ratio between metastatic and examined lymph nodes (N ratio) may have low clinical utility in gastric cancer patients treated by limited lymphadenectomy: results from a single-center experience of 526 patients [J]. World J Surg. 2010;34(1):85–91.CrossRef Pedrazzani C, Sivins A, et al. Ratio between metastatic and examined lymph nodes (N ratio) may have low clinical utility in gastric cancer patients treated by limited lymphadenectomy: results from a single-center experience of 526 patients [J]. World J Surg. 2010;34(1):85–91.CrossRef
7.
go back to reference Chen S, Zhao BW, Li YF, et al. The prognostic value of harvested lymph nodes and the metastatic lymph node ratio for gastric cancer patients: results of a study of 1,101 patients [J]. PLoS One. 2011;7(11):e49424.CrossRef Chen S, Zhao BW, Li YF, et al. The prognostic value of harvested lymph nodes and the metastatic lymph node ratio for gastric cancer patients: results of a study of 1,101 patients [J]. PLoS One. 2011;7(11):e49424.CrossRef
8.
go back to reference Manzoni GD, Verlato G, Roviello F, et al. The new TNM classification of lymph node metastasis minimizes stage migration problems in gastric cancer patients [J]. Br J Cancer. 2002;87(2):171–4.CrossRef Manzoni GD, Verlato G, Roviello F, et al. The new TNM classification of lymph node metastasis minimizes stage migration problems in gastric cancer patients [J]. Br J Cancer. 2002;87(2):171–4.CrossRef
9.
go back to reference Okusa T, Nakane Y, Boku T, et al. Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma. [J]. Surg Gynecol Obstet. 1990;170(6):488–94.PubMed Okusa T, Nakane Y, Boku T, et al. Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma. [J]. Surg Gynecol Obstet. 1990;170(6):488–94.PubMed
10.
go back to reference Inoue K, Nakane Y, Iiyama H, et al. The superiority of ratio-based lymph node staging in gastric carcinoma [J]. Ann Surg Oncol. 2002;9(1):27–34.CrossRef Inoue K, Nakane Y, Iiyama H, et al. The superiority of ratio-based lymph node staging in gastric carcinoma [J]. Ann Surg Oncol. 2002;9(1):27–34.CrossRef
11.
go back to reference Nitti D, Marchet A, Olivieri M, et al. Ratio between metastatic and examined lymph nodes was an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European Monoinstitutional experience [J]. Ann Surg Oncol. 2003;10(9):1077–85.CrossRef Nitti D, Marchet A, Olivieri M, et al. Ratio between metastatic and examined lymph nodes was an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European Monoinstitutional experience [J]. Ann Surg Oncol. 2003;10(9):1077–85.CrossRef
12.
go back to reference Celen O, Yildirim E, Berberoglu U. Prognostic impact of positive lymph node ratio in gastric carcinoma [J]. J Surg Oncol. 2007;96(2):95–101.CrossRef Celen O, Yildirim E, Berberoglu U. Prognostic impact of positive lymph node ratio in gastric carcinoma [J]. J Surg Oncol. 2007;96(2):95–101.CrossRef
13.
go back to reference Marchet A, Mocellin S, Ambrosi A, et al. The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients.[J]. Ann Surg. 2007;245(4):543–52.CrossRef Marchet A, Mocellin S, Ambrosi A, et al. The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients.[J]. Ann Surg. 2007;245(4):543–52.CrossRef
14.
go back to reference Association J G C. Japanese classification of gastric carcinoma: 3rd English edition [J]. Gastric Cancer. 2011;14(2):101–12.CrossRef Association J G C. Japanese classification of gastric carcinoma: 3rd English edition [J]. Gastric Cancer. 2011;14(2):101–12.CrossRef
15.
go back to reference Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009[J]. Ca A Cancer J Clinicians. 2009;59(4):225–49.CrossRef Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009[J]. Ca A Cancer J Clinicians. 2009;59(4):225–49.CrossRef
16.
go back to reference Siewert JR, Böttcher K, Stein HJ, et al. Relevant prognostic factors in gastric cancer: ten-year results of the German gastric cancer study. [J]. Ann Surg. 1998;228(4):449–61.CrossRef Siewert JR, Böttcher K, Stein HJ, et al. Relevant prognostic factors in gastric cancer: ten-year results of the German gastric cancer study. [J]. Ann Surg. 1998;228(4):449–61.CrossRef
17.
go back to reference Wu CW, Hsieh MC, Lo SS, et al. Relation of number of positive lymph nodes to the prognosis of patients with primary gastric adenocarcinoma[J]. Gut. 1996;38(4):525–7.CrossRef Wu CW, Hsieh MC, Lo SS, et al. Relation of number of positive lymph nodes to the prognosis of patients with primary gastric adenocarcinoma[J]. Gut. 1996;38(4):525–7.CrossRef
18.
go back to reference Yokota T, Kunii Y, Teshima S, et al. Significant prognostic factors in patients with early gastric cancer. [J]. Int Surg. 2000;85(4):286–90.PubMed Yokota T, Kunii Y, Teshima S, et al. Significant prognostic factors in patients with early gastric cancer. [J]. Int Surg. 2000;85(4):286–90.PubMed
19.
go back to reference Chu X, Yang ZF. Impact on survival of the number of lymph nodes resected in patients with lymph node-negative gastric cancer [J]. World J Surg Oncol. 2015;13(1):1–8.CrossRef Chu X, Yang ZF. Impact on survival of the number of lymph nodes resected in patients with lymph node-negative gastric cancer [J]. World J Surg Oncol. 2015;13(1):1–8.CrossRef
20.
go back to reference Hsu JT, Lin CJ, Sung CM, et al. Prognostic significance of the number of examined lymph nodes in node-negative gastric adenocarcinoma [J]. Eur J Surg Oncol. 2013;39(11):1287–93.CrossRef Hsu JT, Lin CJ, Sung CM, et al. Prognostic significance of the number of examined lymph nodes in node-negative gastric adenocarcinoma [J]. Eur J Surg Oncol. 2013;39(11):1287–93.CrossRef
21.
go back to reference Jiao XG, Deng JY, Zhang RP, et al. Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer. [J]. World J Gastroenterol. 2014;20(13):3640.CrossRef Jiao XG, Deng JY, Zhang RP, et al. Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer. [J]. World J Gastroenterol. 2014;20(13):3640.CrossRef
22.
go back to reference Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. [J]. J Clin Oncol. 2005;23(23):7114–24.CrossRef Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. [J]. J Clin Oncol. 2005;23(23):7114–24.CrossRef
23.
go back to reference Schwarz RE, Smith DD. Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage [J]. Ann Surg Oncol. 2007;14(2):317–28.CrossRef Schwarz RE, Smith DD. Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage [J]. Ann Surg Oncol. 2007;14(2):317–28.CrossRef
24.
go back to reference Song W, Yuan Y, Wang L, et al. The prognostic value of lymph nodes dissection number on survival of patients with lymph node-negative gastric cancer. [J]. Gastroenterol Res Pract. 2014;2014(1):603194.PubMedPubMedCentral Song W, Yuan Y, Wang L, et al. The prognostic value of lymph nodes dissection number on survival of patients with lymph node-negative gastric cancer. [J]. Gastroenterol Res Pract. 2014;2014(1):603194.PubMedPubMedCentral
25.
go back to reference Wong SL, Hong J, Hollenbeck BK, et al. Hospital lymph node examination rates and survival after resection for colon cancer [J]. JAMA. 2007;298(18):2149–54.CrossRef Wong SL, Hong J, Hollenbeck BK, et al. Hospital lymph node examination rates and survival after resection for colon cancer [J]. JAMA. 2007;298(18):2149–54.CrossRef
26.
go back to reference Lemmens VEPP, Dassen AE, et al. Lymph node examination among patients with gastric cancer: variation between departments of pathology and prognostic impact of lymph node ratio [J]. Eur J Surg Oncol. 2011;37(6):488–96.CrossRef Lemmens VEPP, Dassen AE, et al. Lymph node examination among patients with gastric cancer: variation between departments of pathology and prognostic impact of lymph node ratio [J]. Eur J Surg Oncol. 2011;37(6):488–96.CrossRef
27.
go back to reference Alatengbaolide LD, Li Y, et al. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes[J]. Am J Clin Oncol. 2013;36(4):325.CrossRef Alatengbaolide LD, Li Y, et al. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes[J]. Am J Clin Oncol. 2013;36(4):325.CrossRef
28.
go back to reference Maduekwe UN, Lauwers GY, Fernandezdelcastillo C, et al. A new metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma [J]. Ann Surg Oncol. 2010;17(5):1267–77.CrossRef Maduekwe UN, Lauwers GY, Fernandezdelcastillo C, et al. A new metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma [J]. Ann Surg Oncol. 2010;17(5):1267–77.CrossRef
29.
go back to reference Ibrahim S. Dogu, et al. does N ratio affect survival in D1 and D2 lymph node dissection for gastric cancer? World J Gastroenterol. 2011;17(35):4007–12.CrossRef Ibrahim S. Dogu, et al. does N ratio affect survival in D1 and D2 lymph node dissection for gastric cancer? World J Gastroenterol. 2011;17(35):4007–12.CrossRef
30.
go back to reference Persiani R, Rausei S, et al. Ratio of metastatic lymph nodes: impact on staging and survival of gastric cancer [J]. Eur J Surg Oncol. 2008;34(5):519–24.CrossRef Persiani R, Rausei S, et al. Ratio of metastatic lymph nodes: impact on staging and survival of gastric cancer [J]. Eur J Surg Oncol. 2008;34(5):519–24.CrossRef
Metadata
Title
Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer
Authors
Yi Hou
Xudong Wang
Jing Chen
Publication date
01-12-2018
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2018
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-018-1504-5

Other articles of this Issue 1/2018

World Journal of Surgical Oncology 1/2018 Go to the issue